1. OPLEIDING

    Upcoming events

    Our Lectures

    de Duve Lectures
    J.-F. Heremans Lectures

    onze jaarlijkse verslagen

    Het laatste nummer
    Onze oude jaarlijkse verslagen

    Jan

    23

    2017

    The Impact of Physical Activity and Antioxidants on Signaling Pathways Involved in Tumor Growth and Skeletal Muscle Wasting
    Maandag 23 Januari 2017, van 14:00 tot 15:00
    de Visscher Auditorium
    Mohamad ASSI, Laboratory "Movement, Sport, Health Sciences", University of Rennes 2, FRANCE
    Contact Patrick Jacquemin
    de Duve Institute Seminar

    Jan

    19

    2017

    Deciphering the cellular hierarchy of the mammary gland and its relation with breast cancer initiation
    Donderdag 19 Januari 2017, van 12:00 tot 13:00
    de Visscher Auditorium
    Alexandra VAN KEYMEULEN, IRIBHM, ULB
    Contact Patrick Jacquemin
    de Duve Institute Seminar

    Jan

    19

    2017

    "Proteasome-catalysed peptide splicing and its biological implications" & "From in silico to the clinic: methods to study proteasome-catalysed peptide splicing"
    Donderdag 19 Januari 2017, van 10:00 tot 11:00
    de Visscher Auditorium
    Michele MISHTO, Institute of Biochemistry, University of Medicine Charite, Berlin, GERMANY & Juliane LIEPE, Center for Bioinformatics, Imperial College, London, UK
    Contact Stefan Constantinescu
    Joint de Duve Institute Seminar

    Jan

    18

    2017

    SMIT1 mediates the production of reactive oxygen species induced by hyperglycemia in the heart
    Woensdag 18 Januari 2017, van 17:00 tot 21:00
    de Visscher Auditorium
    Anne VAN STEENBERGEN (Promoter: Christophe BEAULOYE)
    Contact Julie Klein
    Public PhD Thesis Defense

    Jan

    13

    2017

    Regulation of inflammation and tumorigenesis by ARE-mediated mRNA decay
    Vrijdag 13 Januari 2017, van 12:00 tot 13:00
    de Visscher Auditorium
    Stanislas GORIELY, Institute for Medical Immunology, ULB, Gosselies, BELGIQUE
    Contact Laure Dumoutier
    de Duve Institute Seminar

    SEMINARS